|

Algorand presents buying opportunity before ALGO hits $1.25

  • Algorand price continues to form a new support zone before initiating a new breakout.
  • Massive Ichimoku gaps point to an imminent mean reversion setup.
  • Downside risks remain likely but are limited in scope.

Algorand price action is currently struggling to capitalize on last week’s rally. Despite last week’s candlestick closing in the red, it did print a bullish hammer reversal pattern after ALGO rallied more than 20% from the weekly lows.

Algorand price positioned for a massive 50% spike

Algorand price has developed some of the last gaps between the weekly candlesticks and the Tenkan-Sen than any other cryptocurrency. Not only are the gaps huge, but the time spent without a mean reversion is at the end of when an instrument is expected to return to the Tenkan-Sen. Generally, the gaps between the bodies of the candlesticks and the Tenkan-Sen resolve within three to six periods – ALGO is in its sixth day of consecutive gaps.

ALGO/USDT Weekly Ichimoku Kinko Hyo Chart

Another contributing factor pointing to an imminent bullish bounce is the oversold nature of ALGO’s oscillators. The Optex Bands oscillator is at an all-time low, and the Composite Index is at the second-lowest low in its history. Combining the significant Ichimoku gaps and the extreme oversold conditions in the oscillators has generated an early entry opportunity on the Algorand price Point and Figure chart.

A hypothetical long setup is now present on the $0.05/3-box reversal Point and Figure chart. The setup is a buy stop order at $0.90, a profit target at $0.75, and a profit target at $1.45. The trade represents a 3.67:1 reward for the risk. A two-box trailing stop would help protect any profit generated post entry.

ALGO/USDT $0.05/3-box Reversal Point and Figure Chart

The hypothetical long trade is invalidated if Algorand price drops to $0.70 before the entry is triggered.

Author

Jonathan Morgan

Jonathan Morgan

Independent Analyst

Jonathan has been working as an Independent future, forex, and cryptocurrency trader and analyst for 8 years. He also has been writing for the past 5 years.

More from Jonathan Morgan
Share:

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

By subscribing you agree to our Terms and conditions.

Editor's Picks

Ripple faces persistent bear risks, shrugging off ETF inflows

Ripple is extending its decline for the second consecutive day, trading at $2.06 at the time of writing on Friday. Sentiment surrounding the cross-border remittance token continues to lag despite steady inflows into XRP spot ETFs. 

Luna Classic soars 20% as Do Kwon's sentence hearing looms

Luna Classic surges 20% on Friday, extending its recovery for the fourth consecutive day. Roughly 959 million tokens have been burned in December so far, fueling LUNC's recovery.

Crypto Today: Bitcoin, Ethereum, XRP pare gains despite increasing hopes of upcoming Fed rate cut

Bitcoin (BTC) is steadying above $91,000 at the time of writing on Friday. Resistance at $94,150 capped recovery on Wednesday, but in the meantime, bulls have contained downside risks above $90,000. 

Ethereum strengthens against BTC post-Fusaka, targeting $3,200 breakout

Ethereum trades above $3,100 on Friday, with bulls aiming for a breakout above a two-month-old resistance trendline. Ethereum gains strength against Bitcoin as demand for the major altcoin increases after the Fusaka upgrade.

Orange Juice Newsletter – Smart insights by real people. Every day.

A free newsletter highlighting key market trends to help traders stay a step ahead. Daily insights on the most relevant trading topics, compiled by our experts in an easy-to-read format so you never miss an important move.

Crypto Today: Bitcoin, Ethereum, XRP pare gains despite increasing hopes of upcoming Fed rate cut

Bitcoin (BTC) is steadying above $91,000 at the time of writing on Friday. Resistance at $94,150 capped recovery on Wednesday, but in the meantime, bulls have contained downside risks above $90,000.